Alignment reached on chemistry, manufacturing, and control (CMC) elements of ATH434 Phase 3 development program – – Positive feedback supports ...

Alignment reached on chemistry, manufacturing, and control (CMC) elements of ATH434 Phase 3 development program - - Positive feedback supports readiness for Phase 3 initiation with manufacturing ...

Highlights Aligned with the FDA in two Positive Type C meetings supporting key elements of the planned Phase 3 program for ATH434 in MSAAdvancing ...

Alignment reached on chemistry, manufacturing, and control (CMC) elements of ATH434 Phase 3 development program – – Positive feedback supports readiness for Phase 3 initiation with manufacturing scale ...

Investing.com -- BioArctic shares fell about 5% on Tuesday after Goldman Sachs cut the stock to "neutral" from "buy," saying ...

Pomerantz LLP is investigating claims on behalf of investors of Theravance Biopharma, Inc. ("Theravance" or the "Company") .  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.

Kodiak Sciences Inc. , a precommercial retina-focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, today announced it will present ...

Leqembi, which was approved in 2023 to treat the mind-robbing disease, generated $168 million in sales, up 74 percent from ...

So what does that mean for us moving forward?​ The future will always be human-centric because we are. Whether you’re at an ...

Ocular Therapeutix has initiated a long-term extension trial evaluating the investigational intravitreal therapy AXPAXLI in ...

Here’s why your obsession with stretching is actually keeping you tight and how to finally find relief. If your hamstrings ...